This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Brown University, Women and Infants' Hospital Rhode Island, Women & Infants' Hospital. Active years: 2012-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Warwick, RI (US) (2012)
- Cranston, RI (US) (2013 - 2015)
Company Filing History:
2 out of 493 
2 out of 2 
1 out of 5 Years Active: 2012-2015
Title: Kyu Kwang Kim: Innovator in Cancer Treatment
Introduction
Kyu Kwang Kim is a notable inventor based in Cranston, RI (US). He has made significant contributions to the field of medicine, particularly in the treatment of cancer. With a total of 3 patents, his work focuses on innovative solutions that aim to improve patient outcomes.
Latest Patents
One of Kyu Kwang Kim's latest patents involves nitrofuran compounds for the treatment of cancer and angiogenesis. This invention is directed to the synthesis and use of nitrofuran compounds, especially Nifurtimox, as medicaments to treat cancer, particularly neuroblastoma, and to inhibit angiogenesis. The invention also provides compositions, unit dosage forms, and kits comprising these compounds. This groundbreaking work has the potential to change the landscape of cancer treatment.
Career Highlights
Throughout his career, Kyu Kwang Kim has worked with esteemed institutions such as Brown University and Women and Infants' Hospital Rhode Island. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.
Collaborations
Kyu Kwang Kim has collaborated with notable professionals, including Rakesh Kumar Singh and Laurent Brard. These partnerships have further enriched his research and development efforts in the medical field.
Conclusion
Kyu Kwang Kim's innovative work in the synthesis of nitrofuran compounds showcases his dedication to advancing cancer treatment. His contributions are invaluable to the medical community and hold promise for future breakthroughs in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile